2007: SLE: Novel Therapies
Search or Browse by Day

SLE: Novel Therapies

1315
MEDI-545, an Anti-Interferon Alpha Monoclonal Antibody, Shows Evidence of Clinical Activity in Systemic Lupus Erythematosus
1316
Novel Combined Response Endpoint and Systemic Lupus Erythematosus (SLE) Flare Index (SFI) Demonstrate Belimumab (Fully Human Monoclonal Antibody to BLyS) Improves or Stabilizes SLE Disease Activity and Reduces Flare Rate Over 2.5 Years of Therapy
1317
A Randomised Placebo-Controlled Interventional Trail of Omega-3-Polyunsaturated Fatty Acids on Disease Activity and Endothelial Function in Systemic Lupus Erythematosus
1318
Peptide Mimotope of DNA Blocks Toll Like Receptor (TLR) 9 Activation
1319
Memantine in Systemic Lupus Erythematosus: A Randomized Double-Blind Placebo-Controlled Trial
1320
Efficacy of Fulvestrant-an Estrogen Receptor Blocker-in Human SLE: A One-Year Double-Blind Placebo-Controlled Trial; Clinical, Serological, Bone Density, and Molecular Studies
See more of: ACR Abstract Submission ACR Concurrent Abstract Session
<< Previous Session Level | Next Session Level >>